BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 27377501)

  • 1. Association of BCL11A genetic variant (rs11886868) with severity in β-thalassaemia major & sickle cell anaemia.
    Dadheech S; Madhulatha D; Jainc S; Joseph J; Jyothy A; Munshi A
    Indian J Med Res; 2016 Apr; 143(4):449-54. PubMed ID: 27377501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Xmn1 -158 γG variant with severity and HbF levels in β-thalassemia major and sickle cell anaemia.
    Dadheech S; Jain S; Madhulatha D; Sharma V; Joseph J; Jyothy A; Munshi A
    Mol Biol Rep; 2014 May; 41(5):3331-7. PubMed ID: 24488321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
    Chaouch L; Moumni I; Ouragini H; Darragi I; Kalai M; Chaouachi D; Boudrigua I; Hafsia R; Abbes S
    Hematology; 2016 Aug; 21(7):425-9. PubMed ID: 27077760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.
    Rujito L; Basalamah M; Siswandari W; Setyono J; Wulandari G; Mulatsih S; Sofro AS; Sadewa AH; Sutaryo S
    Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):55-63. PubMed ID: 27009595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between hemoglobin F levels and single nucleotide polymorphism at BCL11A gene rs11886868 locus in β-thalassemia patients].
    Chen QR; Sun SC; Peng YS; Wang Q; Mo BM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):650-3. PubMed ID: 22739175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.
    Friedrisch JR; Sheehan V; Flanagan JM; Baldan A; Summarell CC; Bittar CM; Friedrisch BK; Wilke II; Ribeiro CB; Daudt LE; da Rocha Silla LM
    Blood Cells Mol Dis; 2016 Nov; 62():32-37. PubMed ID: 27838552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.
    Pereira C; Relvas L; Bento C; Abade A; Ribeiro ML; Manco L
    Blood Cells Mol Dis; 2015 Apr; 54(4):315-20. PubMed ID: 25842369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association of G779A ZHX-2 gene variant with HbF levels in β-thalassemia major.
    Munshi A; Dadheech S; Jain S; Joseph J; Al-Hazzani A; Alshatwi AA; Sai Babu M; Rajeshwar K; Jyothy A
    Eur J Haematol; 2011 Jun; 86(6):502-6. PubMed ID: 21443521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.
    Muszlak M; Pissard S; Badens C; Chamouine A; Maillard O; Thuret I
    Hemoglobin; 2015; 39(3):156-61. PubMed ID: 25806420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Novel Role of the B-Cell Lymphoma/Leukemia 11A (BCL11A) Gene in β-Thalassaemia Treatment.
    Mahmoud Ahmed NH; Lai MI
    Cardiovasc Hematol Disord Drug Targets; 2023; 22(4):226-236. PubMed ID: 36734897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic basis of asymptomatic codon 8 frame-shift (HBB:c25_26delAA) β(0) -thalassaemia homozygotes.
    Jiang Z; Luo HY; Huang S; Farrell JJ; Davis L; Théberge R; Benson KA; Riolueang S; Viprakasit V; Al-Allawi NA; Ünal S; Gümrük F; Akar N; Başak AN; Osorio L; Badens C; Pissard S; Joly P; Campbell AD; Gallagher PG; Steinberg MH; Forget BG; Chui DH
    Br J Haematol; 2016 Mar; 172(6):958-65. PubMed ID: 26771086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background.
    Neishabury M; Zamani F; Keyhani E; Azarkeivan A; Abedini SS; Eslami MS; Kakroodi ST; Vesiehsari MJ; Najmabadi H
    Blood Cells Mol Dis; 2013 Aug; 51(2):80-4. PubMed ID: 23541515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic determinants related to pharmacological induction of foetal haemoglobin in transfusion-dependent HbE-β thalassaemia.
    Biswas S; Nag A; Ghosh K; Ray R; Roy K; Bandyopadhyay A; Bhattacharyya M
    Ann Hematol; 2019 Feb; 98(2):289-299. PubMed ID: 30413899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sickle cell disease in Madhya Pradesh, Central India: A comparison of clinical profile of sickle cell homozygote vs. sickle-beta thalassaemia individuals.
    Yadav R; Lazarus M; Ghanghoria P; Singh M; Gupta RB; Kumar S; Sharma RK; Shanmugam R
    Hematology; 2016 Oct; 21(9):558-63. PubMed ID: 27077770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.
    Uda M; Galanello R; Sanna S; Lettre G; Sankaran VG; Chen W; Usala G; Busonero F; Maschio A; Albai G; Piras MG; Sestu N; Lai S; Dei M; Mulas A; Crisponi L; Naitza S; Asunis I; Deiana M; Nagaraja R; Perseu L; Satta S; Cipollina MD; Sollaino C; Moi P; Hirschhorn JN; Orkin SH; Abecasis GR; Schlessinger D; Cao A
    Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1620-5. PubMed ID: 18245381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal hemoglobin regulating genetic variants identified in homozygous (HbSS) and heterozygous (HbSA) subjects from South Mexico.
    Rizo-de la Torre LC; Borrayo-López FJ; Perea-Díaz FJ; Aquino E; Venegas M; Hernández-Carbajal C; Espinoza-Mata LL; Ibarra-Cortés B
    J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36130307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon.
    Wonkam A; Ngo Bitoungui VJ; Vorster AA; Ramesar R; Cooper RS; Tayo B; Lettre G; Ngogang J
    PLoS One; 2014; 9(3):e92506. PubMed ID: 24667352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
    El-Ghamrawy M; Yassa ME; Tousson AMS; El-Hady MA; Mikhaeil E; Mohamed NB; Khorshied MM
    Ann Hematol; 2020 Oct; 99(10):2279-2288. PubMed ID: 32772141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
    Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
    Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Salah NY; Ali HGA; Bassiouny N; Salem L; Taha SI; Youssef MK; Annaka L; Barakat NM
    J Pediatr Genet; 2023 Mar; 12(1):16-22. PubMed ID: 36684548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.